Appropriate selection of participants in pediatric developmental and epileptic encephalopathy trials: Lessons learned and future opportunities

Documenti analoghi

• Bexicaserin for the treatment of seizures in developmental and epileptic encephalopathies: A phase 1b/2a trial ( PACIFIC )
  di: Dennis J. Dlugos, et al.
  Pubblicazione: (2025)
• Operational definition of developmental and epileptic encephalopathies to underpin the design of therapeutic trials
  di: Ingrid E. Scheffer, et al.
  Pubblicazione: (2025)
• Girdin deficiency causes developmental and epileptic encephalopathy with hippocampal sclerosis and interneuronopathy
  di: Machiko Iida, et al.
  Pubblicazione: (2024)
• Drug discovery and preclinical testing of drug candidates for developmental and epileptic encephalopathies
  di: Heidrun Potschka, et al.
  Pubblicazione: (2025)
• Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy
  di: Cathrine E. Gjerulfsen, et al.
  Pubblicazione: (2025)